# Efficacy and Safety of Rifaximin for Patients With Chronic Intestinal Pseudo-obstruction: a Phase 2 Trial

> **NCT04118699** · PHASE2 · UNKNOWN · sponsor: **Yokohama City University** · enrollment: 12 (estimated)

## Conditions studied

- Chronic Intestinal Pseudo-obstruction

## Interventions

- **DRUG:** Rifaximin oral tablet
- **DRUG:** Placebo oral tablet

## Key facts

- **NCT ID:** NCT04118699
- **Lead sponsor:** Yokohama City University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-12-25
- **Primary completion:** 2021-11
- **Final completion:** 2022-01
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2021-06-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04118699

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04118699, "Efficacy and Safety of Rifaximin for Patients With Chronic Intestinal Pseudo-obstruction: a Phase 2 Trial". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04118699. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*